Hepatobiliary & Liver Transplant SurgeryABO-Incompatible Liver Transplant
Advancement and Recent Trends in Liver Transplant and ABO-Incompatible Liver Transplantation: Current Strategies & Outcomes
Dr. Dheeraj Manchanda
Associate Consultant - HPB Surgery and Liver Transplantation
BLK-Max Super Speciality Hospital, New Delhi, India
Masterclass held Published
Dr. Dheeraj Manchanda, Associate Consultant - HPB Surgery and Liver Transplantation, BLK-Max Super Speciality Hospital, New Delhi, India, explains how rituximab, plasmapheresis and early immunosuppression make ABO-incompatible liver transplant possible, alongside robotic donor hepatectomy, dual-lobe and paediatric grafts, and combined liver-kidney transplant. The session also sets out the MELD thresholds for referral, the tacrolimus targets that protect the kidneys, and long-term outcomes after transplant.
Access the Article Series
- 1.Recent Advances in Liver Transplant: A Complete Guide
- 2.ABO-Incompatible Liver Transplant and Complex Cases
- 3.Robotic Donor Hepatectomy: Technique, Recovery and Safety
- 4.Immunosuppression After Liver Transplant: Tacrolimus Levels
- 5.Live Discussion: 12 questions from doctors, answered by Dr. Dheeraj Manchanda
Book a Consultation with Dr. Dheeraj Manchanda
Book on WhatsAppOr message us on WhatsApp: +91 98182 98669